InsidersTradesSigma
Follow the Xenetic Biosciences, Inc. stock price and the full insider trade history of the company, a listed issuer based in United States. Shares are quoted on the US market, under the supervision of SEC (Form 4). Market capitalisation: €7.6m. The latest transaction was reported on 23 April 2026 (Attribution). Among the most active insiders: PARSLOW JAMES F. Every trade is openly available.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
1 of 1 declaration
Xenetic Biosciences, Inc. es una empresa biofarmacéutica centrada en el desarrollo de terapias innovadoras para enfermedades graves. Aprovecha tecnologías avanzadas para mejorar la eficacia de los tratamientos.